Smartleaf Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Smartleaf Asset Management's VRTX Position: Q1 2026 in Review
Smartleaf Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q1 2026, buying an estimated $259K and bringing the position to 4,540 shares worth $2.01M. The position accounts for 0.07% of the portfolio, ranked #244.
Smartleaf Asset Management first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Smartleaf Asset Management held 4,540 shares of Vertex Pharmaceuticals worth $2.01M as of Q1 2026.
- Smartleaf Asset Management bought 555 Vertex Pharmaceuticals shares in Q1 2026, an estimated $259K.
- Vertex Pharmaceuticals made up 0.07% of Smartleaf Asset Management's portfolio in Q1 2026, its #244 holding.
- Smartleaf Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.